Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
University of Alabama at Birmingham
University of Alabama at Birmingham
iOMEDICO AG
DualityBio Inc.
Tanabe Pharma America, Inc.
Massive Bio, Inc.
Weill Medical College of Cornell University
CNAO National Center of Oncological Hadrontherapy
Marengo Therapeutics, Inc.
Stanford University
Centre Hospitalier Universitaire de Nīmes
Cancer Research UK
Fujian Cancer Hospital
Evopoint Biosciences Inc.
Myeloid Therapeutics
Charite University, Berlin, Germany